BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine

• Published in: Antimicrobial Agents and Chemotherapy 1991-02, Vol.35 (2), p.305-308
• Main Authors: RICHMAN, D, ROSENTHAL, A. S, SKOOG, M, ECKNER, R. J, TING-CHAO CHOU, SABO, J. P, MERLUZZI, V. J
• Format: Article
• Language: English
• Subjects: Antibiotics. Antiinfectious agents. Antiparasitic agents; Antigens, Viral - immunology; Antiviral Agents; Antiviral Agents - pharmacology; Biological and medical sciences; Cytopathogenic Effect, Viral - drug effects; Drug Resistance, Microbial; Drug Synergism; HeLa Cells - drug effects; HIV-1; HIV-1 - drug effects; HIV-2 - drug effects; human immunodeficiency virus 1; Humans; Macrophages - drug effects; Medical sciences; Nevirapine; Pharmacology. Drug treatments; Picornaviridae - drug effects; Pyridines; Pyridines - pharmacology; Research Article; Reverse Transcriptase Inhibitors; T-Lymphocytes - drug effects; Viral Plaque Assay; Zidovudine; Zidovudine - pharmacology
• ISSN: 0066-4804; 1098-6596
• DOI: 10.1128/AAC.35.2.305

Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • [e-mail] Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC